Little Evidence for the Benefits of Vitamin D Supplementation for Health Problems

Summary: Researchers review and evaluate the scientific evidence behind the ten most common beliefs about vitamin D and its health effects.

Source: University of Alberta

As Canadians and others head into months with more sunshine, attention often turns to vitamin D—an essential nutrient produced in the skin through sun exposure and available in some foods and supplements. A recent narrative review led by G. Michael Allan of the University of Alberta examines the best available evidence behind ten widely held beliefs about vitamin D and finds that, for most claims, the scientific support is limited.

What the review examined

The review, published in the Journal of General Internal Medicine, critically analyzed randomized controlled trials and systematic reviews addressing ten common assertions about vitamin D. These included whether vitamin D supplementation prevents falls and fractures, reduces cancer incidence or mortality, prevents respiratory infections, improves depression or mental well‑being, prevents or treats rheumatoid arthritis and multiple sclerosis, and whether routine testing or very large “mega‑doses” are appropriate.

Main findings in brief

Overall, the strongest and most consistent evidence supports a modest benefit of vitamin D in reducing fractures and possibly lowering the rate of falls, especially in older adults. The review estimates a relative fracture reduction on the order of 10–15 percent when vitamin D is given at doses of about 800 IU per day combined with calcium. There may also be a small (~5%) relative reduction in overall mortality, though this finding is uncertain.

For many other commonly claimed benefits—such as preventing cancer, preventing respiratory tract infections, treating or preventing rheumatoid arthritis, treating multiple sclerosis, or improving depression and general mental well‑being—the evidence from randomized trials is lacking or inconsistent. The review also cautions against routine testing of 25‑hydroxyvitamin D levels for most people and notes that very large single doses (often described as mega‑doses, e.g., doses at or above 300,000 IU) appear to increase the risk of harm.

Interpretation and clinical relevance

Michael Allan, professor of Family Medicine and director of Evidence Based Medicine at the University of Alberta, notes the appeal of a simple, low‑risk intervention like a vitamin pill. However, he emphasizes that for the average healthy adult the measurable benefits are minimal or absent. He explains that even in groups at relatively high risk of fracture, the absolute benefit is small: treating a high‑risk group with reasonable vitamin D dosing for ten years might prevent roughly one fracture per 50 people over that time.

Allan and coauthors point out an important nuance: observational studies often show associations between low vitamin D levels and poor health outcomes, but association does not prove causation. Many of those earlier studies raised hope that supplementation would translate into clear clinical benefits; randomized trials and higher‑quality evidence have generally failed to confirm most of those expectations.

Quality of the evidence

The review highlights substantial limitations across much of the vitamin D research: many studies are small, underpowered, or at high risk of bias; some analyses rely on secondary endpoints; and trial results are often inconsistent. Because of these methodological issues, enthusiasm for vitamin D as a panacea should be tempered and future research should focus on better‑designed, adequately powered trials.

Practical takeaways

• Vitamin D supplementation at moderate doses (for example, around 800 IU daily, often combined with calcium in studies) shows the clearest evidence for a modest reduction in fractures and may reduce fall rates in older adults.
• There is little randomized‑trial evidence to support vitamin D supplementation for preventing cancer, respiratory infections, rheumatoid arthritis, multiple sclerosis, or for reliably improving depression or overall mental well‑being.
• Routine testing of vitamin D levels is not required for most people, and very large single doses appear to carry increased risk.
• For the average healthy adult, moderate vitamin D supplementation is unlikely to cause harm but, based on current evidence, is also unlikely to provide measurable health benefits beyond bone health in specific at‑risk groups.

About the research

Article: “Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs” by G. Michael Allan, Lynda Cranston, Adrienne Lindblad, James McCormack, Michael R. Kolber, Scott Garrison, and Christina Korownyk. Journal of General Internal Medicine. Published online March 7, 2016. DOI: 10.1007/s11606-016-3645-y.

Reporting: Shelby Soke, University of Alberta.

---

Abstract (summary)

Observational studies over the past decade have linked lower 25‑hydroxyvitamin D levels to various acute and chronic disorders, prompting hypotheses that higher vitamin D intake could prevent or treat those conditions. This narrative review evaluated randomized trials and high‑level evidence for ten common beliefs about vitamin D, including effects on falls, fractures, respiratory infections, cancer incidence and mortality, overall mortality, depression, rheumatoid arthritis and multiple sclerosis, as well as questions about dosing and routine testing. The evidence supports a modest benefit for fracture prevention (likely ~10–15% relative reduction), particularly with doses ≥800 IU combined with calcium, and a probable benefit in reducing fall rates. A small potential reduction in overall mortality (≈5%) is possible but uncertain. Evidence does not support vitamin D supplementation for preventing cancer, respiratory infections or rheumatoid arthritis, nor for treating multiple sclerosis, rheumatoid arthritis or depression/mental well‑being. Regular 25‑hydroxyvitamin D testing is generally unnecessary for most individuals, and very large single doses increase the risk of harm. Much of the available evidence is at high risk of bias and contains multiple methodological flaws, so claims of broad health benefits from vitamin D should be viewed cautiously.